IL5 and eosinophilic granulomatosis with polyangiitis: Two seropositive EGPA cases with raised serum IL-5 concentrations and increased peripheral eosinophil counts received the RTX treatment, due to their refractory activity to CS and CYC induction, resulting in clinical responses with undetectable IL-5 levels and reduced eosinophil numbers [47].